References
- Orsenigo E, Tomajer V, Palo SD, Carlucci M, Vignali A, Tamburini A, et al. Impact of age on postoperative outcomes in 1118 gastric cancer patients undergoing surgical treatment. Gastric Cancer 2007;10:39-44. https://doi.org/10.1007/s10120-006-0409-0
- Jun JK, Choi KS, Lee HY, Suh M, Park B, Song SH, et al. Effectiveness of the Korean National Cancer Screening Program in reducing gastric cancer mortality. Gastroenterology 2017;152:1319-1328.e7. https://doi.org/10.1053/j.gastro.2017.01.029
- Hwang SH, Park DJ, Jee YS, Kim HH, Lee HJ, Yang HK, et al. Risk factors for operative complications in elderly patients during laparoscopy-assisted gastrectomy. J Am Coll Surg 2009;208:186-192. https://doi.org/10.1016/j.jamcollsurg.2008.10.023
- Seo HS, Jung YJ, Kim JH, Park CH, Lee HH. Necessity of D2 lymph node dissection in older patients ≥80 years with gastric cancer. J Geriatr Oncol 2018;9:115-119. https://doi.org/10.1016/j.jgo.2017.09.006
- Bouliaris K, Rachiotis G, Diamantis A, Christodoulidis G, Polychronopoulou E, Tepetes K. Lymph node ratio as a prognostic factor in gastric cancer patients following D1 resection. Comparison with the current TNM staging system. Eur J Surg Oncol 2017;43:1350-1356. https://doi.org/10.1016/j.ejso.2017.03.013
- Kim Y, Squires MH, Poultsides GA, Fields RC, Weber SM, Votanopoulos KI, et al. Impact of lymph node ratio in selecting patients with resected gastric cancer for adjuvant therapy. Surgery 2017;162:285-294. https://doi.org/10.1016/j.surg.2017.03.023
- Komatsu S, Ichikawa D, Miyamae M, Kosuga T, Okamoto K, Arita T, et al. Positive lymph node ratio as an indicator of prognosis and local tumor clearance in N3 gastric cancer. J Gastrointest Surg 2016;20:1565-1571. https://doi.org/10.1007/s11605-016-3197-9
- Nelen SD, van Steenbergen LN, Dassen AE, van der Wurff AA, Lemmens VE, Bosscha K. The lymph node ratio as a prognostic factor for gastric cancer. Acta Oncol 2013;52:1751-1759. https://doi.org/10.3109/0284186X.2012.754991
- Yamashita H, Deng J, Liang H, Seto Y. Re-evaluating the prognostic validity of the negative to positive lymph node ratio in node-positive gastric cancer patients. Surgery 2017;161:1588-1596. https://doi.org/10.1016/j.surg.2016.12.018
- Yamashita K, Hosoda K, Ema A, Watanabe M. Lymph node ratio as a novel and simple prognostic factor in advanced gastric cancer. Eur J Surg Oncol 2016;42:1253-1260. https://doi.org/10.1016/j.ejso.2016.03.001
- Zhu J, Xue Z, Zhang S, Guo X, Zhai L, Shang S, et al. Integrated analysis of the prognostic role of the lymph node ratio in node-positive gastric cancer: a meta-analysis. Int J Surg 2018;57:76-83. https://doi.org/10.1016/j.ijsu.2018.08.002
- Wohnrath DR, Araujo RL. Positive node-ratio in curative-intent treatment for gastric cancer is a strong independent prognostic factor for 5-year overall survival. J Surg Oncol 2020;121:777-783. https://doi.org/10.1002/jso.25755
- Hwang JE, Kim H, Shim HJ, Bae WK, Hwang EC, Jeong O, et al. Lymph-node ratio is an important clinical determinant for selecting the appropriate adjuvant chemotherapy regimen for curative D2-resected gastric cancer. J Cancer Res Clin Oncol 2019;145:2157-2166. https://doi.org/10.1007/s00432-019-02963-7
- Guideline Committee of the Korean Gastric Cancer Association (KGCA), Development Working Group & Review Panel. Korean Practice Guideline for Gastric Cancer 2018: an evidence-based, multi-disciplinary approach. J Gastric Cancer 2019;19:1-48. https://doi.org/10.5230/jgc.2019.19.e8
- Lee YC, Yang PJ, Zhong Y, Clancy TE, Lin MT, Wang J. Lymph node ratio-based staging system outperforms the seventh AJCC system for gastric cancer: validation analysis with National Taiwan University Hospital Cancer Registry. Am J Clin Oncol 2017;40:35-41. https://doi.org/10.1097/COC.0000000000000110
- Yoshikawa K, Shimada M, Higashijima J, Nakao T, Nishi M, Kashihara H, et al. Limited lymph node dissection in elderly patients with gastric cancer. J Med Invest 2016;63:91-95. https://doi.org/10.2152/jmi.63.91
- Bilici A, Selcukbiricik F, Seker M, Oven BB, Olmez OF, Yildiz O, et al. Prognostic significance of metastatic lymph node ratio in patients with pN3 gastric cancer who underwent curative gastrectomy. Oncol Res Treat 2019;42:209-216. https://doi.org/10.1159/000496746
Cited by
- Lymph Node Ratio System for N Staging of Gastric Cancer: Challenging for Universal Application But Useful for the Prognostic Prediction of Individual Patients vol.21, pp.1, 2021, https://doi.org/10.5230/jgc.2021.21.e10
- A novel pN3 gastric cancer staging system with superior prognostic utility based upon the examination of over 31 lymph nodes: a propensity score-matching analysis vol.21, pp.1, 2021, https://doi.org/10.1186/s12876-021-01928-w